Loading financials from SEC filings…
Software - Application · Technology · Fiscal year ends Dec 31
Cellebrite DI reported revenue of $476M in the fiscal year ended Dec 2025, up 18.6% from the year before. Operating income was $66M, an operating margin of 14.0%, and net income was $78M. Operating cash flow of $174M less capital expenditure of $13M left free cash flow of $160M.
Ranks among the 83 software - application companies we cover (1st = best; for debt, the least indebted). Green = top third, red = bottom third.
Last 5 fiscal years
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 246 | 271 | 325 | 401 | 476 |
| Cost of revenue | 42.6 | 50.7 | 53.2 | 62.6 | 75.2 |
| Gross profit | 204 | 220 | 272 | 339 | 401 |
| Research & development | 65.5 | 80.6 | 84.4 | 98.4 | 114 |
| Selling, general & admin | 124 | 138 | 154 | 183 | 220 |
| Operating income | 13.8 | 1.0 | 33.2 | 56.9 | 66.5 |
| Pre-tax income | 82.3 | 121 | −75.6 | −276 | 90.7 |
| Income tax | 10.9 | −0.0 | 5.5 | 7.0 | 12.4 |
| Net income | 71.4 | 121 | −81.1 | −283 | 78.3 |
| Diluted EPS | 0.44 | 0.59 | −0.43 | −1.35 | 0.31 |
| Diluted shares | 162 | 195 | 190 | 209 | 250 |
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Cash & equivalents | 146 | 87.6 | 190 | 192 | 124 |
| Receivables | 67.5 | 78.8 | 77.3 | 82.4 | 105 |
| Inventory | 6.5 | 10.2 | 9.9 | 8.9 | 7.6 |
| Current assets | 273 | 296 | 422 | 568 | 576 |
| Net PP&E | 16.8 | 17.3 | 15.9 | 17.0 | 22.2 |
| Goodwill | 26.8 | 26.8 | 26.8 | 28.7 | 120 |
| Total assets | 340 | 403 | 533 | 691 | 939 |
| Payables | 9.5 | 4.6 | 8.3 | 11.1 | 16.8 |
| Deferred revenue | 123 | 153 | 196 | 217 | 278 |
| Current liabilities | 187 | 208 | 254 | 296 | 370 |
| Total liabilities | 413 | 329 | 499 | 355 | 455 |
| Shareholders' equity | −73.3 | 73.9 | 34.2 | 336 | 484 |
| Backlog (remaining obligations) | 232 | 276 | – | – | – |
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating cash flow | 36.1 | 20.6 | 102 | 132 | 174 |
| Capital expenditure | 5.1 | 6.9 | 5.2 | 8.6 | 13.2 |
| Free cash flow | 30.9 | 13.7 | 96.8 | 124 | 160 |
| Depreciation & amortisation | 7.0 | 9.2 | 10.0 | 10.6 | 11.9 |
| Stock-based compensation | 6.5 | 13.7 | 19.0 | 30.6 | 44.9 |
| Acquisitions | 20.0 | 0.0 | 0.0 | 2.7 | 147 |
| Share buybacks | 0.0 | 0.0 | – | – | – |
| Dividends paid | 100 | 0.0 | 0.0 | – | – |
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue growth (YoY) | – | 9.9% | 20.1% | 23.4% | 18.6% |
| Operating income growth (YoY) | – | −92.4% | 3083.6% | 71.2% | 16.8% |
| EPS growth (YoY) | – | 34.1% | −172.9% | – | – |
| Gross margin | 82.7% | 81.3% | 83.6% | 84.4% | 84.2% |
| Operating margin | 5.6% | 0.4% | 10.2% | 14.2% | 14.0% |
| Net margin | 29.0% | 44.6% | −24.9% | −70.5% | 16.5% |
| Return on equityBlank when equity is negative | – | 163.5% | −237.1% | −84.2% | 16.2% |
| ROCEEBIT ÷ (assets − current liabilities) | 9.0% | 0.5% | 11.9% | 14.4% | 11.7% |
| Free cash flow margin | 12.6% | 5.1% | 29.8% | 30.8% | 33.7% |
| Cash conversion (CFO ÷ net income) | 0.50x | 0.17x | −1.26x | −0.47x | 2.22x |
| Receivable days | 100 | 106 | 87 | 75 | 81 |
| Inventory days | 56 | 73 | 68 | 52 | 37 |
| Payable days | 82 | 33 | 57 | 65 | 82 |
| Current ratio | 1.46x | 1.42x | 1.66x | 1.92x | 1.56x |
Standardised figures from the company's XBRL filings with the SEC (10-K, 10-Q). Line items follow US GAAP tags, so a company's own statement layout may differ and some lines show “–” where the company does not report that item. Ratios are calculated from these figures. For education only; not investment advice or a recommendation.